Stock Analiz

Milestone Pharmaceuticals Inc. (MIST) stock forecast and price target

Price $0.52 · data as of November 13, 2026

12-month price target

Average target$4.57
Upside / downside+779.1%
Analysts7
ConsensusStrong buy
Low $1.00Average $4.57High $8.00

Gold marker: average target · white marker: today’s price ($0.52)

Analyst ratings

Strong buy 1Buy 5Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.78−3.7%$5M
Next fiscal year
ends December 31, 2027
$-0.64+17.4%$17M
Next quarter
ends December 31, 2026
$-0.21−38.7%$1M
Quarter after
ends March 31, 2027
$-0.15+23.3%$1M

Consensus of the analysts covering Milestone Pharmaceuticals, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Frequently asked questions

What is the Milestone Pharmaceuticals stock price target?

The average 12-month target from 7 analysts is $4.57, 779.1% above the current price of $0.52 Targets range from $1.00 to $8.00.

Is Milestone Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 5 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Milestone Pharmaceuticals expected to earn?

Analysts expect EPS of $-0.78 for the fiscal year ending December 31, 2026 and $-0.64 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.